Quick Answer
UTAH MEDICAL PRODUCTS INC reported Revenue (ASC 606) of $38.52 million for fiscal year 2025.
UTAH MEDICAL PRODUCTS INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $38.52M | -5.8% |
| 2024 | $40.90M | -18.6% |
| 2023 | $50.22M | -3.9% |
| 2022 | $52.28M | +6.6% |
| 2021 | $49.05M | +16.3% |
| 2020 | $42.18M | -10.1% |
| 2019 | $46.90M | +11.7% |
| 2018 | $42.00M | +1.4% |
| 2017 | $41.41M | +5.4% |
| 2016 | $39.30M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.81M | -1.9% | -1.4% |
| June 30, 2025 | $9.95M | -4.3% | +2.5% |
| March 31, 2025 | $9.71M | -14.4% | -2.9% |
| September 30, 2024 | $10.01M | -20.0% | -3.8% |
| June 30, 2024 | $10.40M | -19.2% | -8.3% |
| March 31, 2024 | $11.34M | -9.4% | -9.3% |
| September 30, 2023 | $12.51M | -3.5% | -2.8% |
| June 30, 2023 | $12.87M | -4.2% | +2.8% |
- UTAH MEDICAL PRODUCTS INC showed a decrease of -5.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, UTAH MEDICAL PRODUCTS INC’s revenue (asc 606) has declined by 2.0% (from $39.30 million to $38.52 million).
- The most recent figure is from UTAH MEDICAL PRODUCTS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: